1. Home
  2. CYBN vs KRRO Comparison

CYBN vs KRRO Comparison

Compare CYBN & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYBN
  • KRRO
  • Stock Information
  • Founded
  • CYBN 2019
  • KRRO 2014
  • Country
  • CYBN Canada
  • KRRO United States
  • Employees
  • CYBN N/A
  • KRRO N/A
  • Industry
  • CYBN Pharmaceuticals and Biotechnology
  • KRRO Biotechnology: Pharmaceutical Preparations
  • Sector
  • CYBN Health Care
  • KRRO Health Care
  • Exchange
  • CYBN Nasdaq
  • KRRO Nasdaq
  • Market Cap
  • CYBN 176.5M
  • KRRO 147.4M
  • IPO Year
  • CYBN N/A
  • KRRO 2019
  • Fundamental
  • Price
  • CYBN $6.08
  • KRRO $30.76
  • Analyst Decision
  • CYBN Strong Buy
  • KRRO Strong Buy
  • Analyst Count
  • CYBN 3
  • KRRO 7
  • Target Price
  • CYBN $85.00
  • KRRO $96.71
  • AVG Volume (30 Days)
  • CYBN 625.2K
  • KRRO 241.5K
  • Earning Date
  • CYBN 11-12-2025
  • KRRO 11-11-2025
  • Dividend Yield
  • CYBN N/A
  • KRRO N/A
  • EPS Growth
  • CYBN N/A
  • KRRO N/A
  • EPS
  • CYBN N/A
  • KRRO N/A
  • Revenue
  • CYBN N/A
  • KRRO $6,281,000.00
  • Revenue This Year
  • CYBN N/A
  • KRRO $97.27
  • Revenue Next Year
  • CYBN N/A
  • KRRO N/A
  • P/E Ratio
  • CYBN N/A
  • KRRO N/A
  • Revenue Growth
  • CYBN N/A
  • KRRO N/A
  • 52 Week Low
  • CYBN $4.81
  • KRRO $10.29
  • 52 Week High
  • CYBN $13.88
  • KRRO $98.00
  • Technical
  • Relative Strength Index (RSI)
  • CYBN 38.92
  • KRRO 64.76
  • Support Level
  • CYBN $6.16
  • KRRO $20.20
  • Resistance Level
  • CYBN $6.55
  • KRRO $37.03
  • Average True Range (ATR)
  • CYBN 0.49
  • KRRO 3.59
  • MACD
  • CYBN -0.06
  • KRRO 0.79
  • Stochastic Oscillator
  • CYBN 12.90
  • KRRO 64.15

About CYBN Cybin Inc.

Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of its proprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.

Share on Social Networks: